Expectedly, co-transfection of NEAT1 shRNA and miR-34a inhibitor in cervical cancer cells showed recovered glycolysis and 5-Fu resistance, suggesting that NEAT1 suppressed miR-34a to promote the glycolysis and 5-Fu resistance in cervical cancer. The gene discussed is NEAT1; the disease is cervical cancer.